Prince Pharmaceutical

Prince Pharmaceutical is a Taiwan-based pharmaceutical company established in 1962, specializing in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. The company is particularly recognized for its expertise in Vitamin B1 derivatives, such as Fursultiamine, and offers a broad portfolio of generic medicines across various therapeutic areas including cardiovascular, gastrointestinal, and respiratory health. In addition to its own product line, Prince Pharmaceutical operates as a Contract Development and Manufacturing Organization (CDMO), providing services to global partners. The company maintains high-quality standards with PIC/S GMP certified facilities and exports products to markets across Asia and beyond.